Published in J Thorac Cardiovasc Surg on July 01, 1983
A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart? J Cardiothorac Surg (2014) 0.80
Comparison of antegrade with antegrade/retrograde cold blood cardioplegia for myocardial revascularization. Tex Heart Inst J (1996) 0.77
Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16
Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group. Lancet (1990) 4.98
The pacemaker-twiddler's syndrome: a new complication of implantable transvenous pacemakers. Can Med Assoc J (1990) 3.32
Rapid mapping in Salmonella typhimurium with Mud-P22 prophages. J Bacteriol (1992) 3.29
Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17
Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late? J Am Coll Cardiol (2000) 2.67
Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation (1990) 2.62
Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg (2001) 2.12
Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg (1997) 2.08
Can patients with left main stenosis wait for coronary artery bypass grafting? Ann Thorac Surg (1996) 2.04
Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med (1999) 2.02
Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.93
Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis (1992) 1.91
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J (2000) 1.88
Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg (1998) 1.82
Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol (1996) 1.76
Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg (1989) 1.75
Survival and function of bioengineered cardiac grafts. Circulation (1999) 1.72
Outlet strut fracture of the Björk-Shiley 60 degrees Convexo-Concave valve: current information and recommendations for patient care. J Am Coll Cardiol (1988) 1.70
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation (1997) 1.69
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67
SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66
False aneurysms in the lower extremity. Surg Gynecol Obstet (1967) 1.64
Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg (2001) 1.64
A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg (1992) 1.58
Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol (1997) 1.58
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol (1996) 1.58
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg (1999) 1.54
Saccharomyces cerevisiae mutants unresponsive to alpha-factor pheromone: alpha-factor binding and extragenic suppression. Mol Cell Biol (1987) 1.54
Echocardiography and excision of lipomatous hypertrophy of the interatrial septum. Ann Thorac Surg (1999) 1.50
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg (1988) 1.50
Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart (2006) 1.49
Waiting for coronary revascularization in Toronto: 2 years' experience with a regional referral office. CMAJ (1993) 1.49
Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg (2000) 1.47
Left ventricular functional response to moderate and intense exercise. Can J Sport Sci (1991) 1.45
Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg (2000) 1.44
Comparison of the radial and femoral approaches in left main PCI: a retrospective study. J Invasive Cardiol (2004) 1.42
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg (2000) 1.41
Results of represervation of the chordae tendineae during redo mitral valve replacement. Ann Thorac Surg (1996) 1.41
Renal artery surgery in patients with presumptive renovascular hypertension. Can Med Assoc J (1967) 1.41
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (1996) 1.41
Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg (1996) 1.40
Structures of genes nasA and nasB, encoding assimilatory nitrate and nitrite reductases in Klebsiella pneumoniae M5al. J Bacteriol (1993) 1.40
The "safe" triangle, contrast material, and particulate steroids in lumbar transforaminal injections: What are the right things to do? Clin Radiol (2012) 1.39
Access to cardiac resources in Canada: who is responsible? Who is liable? Can J Cardiol (1999) 1.39
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study. Ann Thorac Surg (1999) 1.39
Report on waiting lists sparks debate. Leadersh Health Serv (1993) 1.39
Autologous pericardial patch without infarctectomy for the treatment of acute cardiac rupture. Can J Cardiol (1995) 1.39
Right-to-left shunt following repair of partial anomalous pulmonary venous connection: a novel use of the Rashkind double-umbrella occlusion device. Cathet Cardiovasc Diagn (1994) 1.39
Hemodynamic determinants of maximum negative dP-dt and periods of diastole. Am J Physiol (1974) 1.38
Postoperative myocardial infarction documented by technetium pyrophosphate scan using single-photon emission computed tomography: significance of intraoperative myocardial ischemia and hemodynamic control. Anesthesiology (1989) 1.38
Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol (1988) 1.38
A thioreduction pathway tethered to the membrane for periplasmic cytochromes c biogenesis; in vitro and in vivo studies. J Mol Biol (1997) 1.37
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart (2001) 1.35
Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA (1994) 1.35
Consequences of postoperative alterations in respiratory mechanics. Am J Surg (1974) 1.34
Clinical performance of Bjork-Shiley mechanical heart valves: a perspective on outlet strut fractures in the 60 degrees and 70 degrees convexo-concave disc models. Can J Cardiol (1988) 1.32
Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation (1998) 1.32
Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation (2000) 1.31
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med (1990) 1.30
Assigning priority to patients requiring coronary revascularization: consensus principles from a panel of cardiologists and cardiac surgeons. Can J Cardiol (1991) 1.29
Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg (2000) 1.24
Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg (1996) 1.24
Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg (1998) 1.23
Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23
Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae. J Thorac Cardiovasc Surg (1984) 1.23
Serial follow-up of adults with repaired tetralogy of Fallot. J Am Coll Cardiol (1992) 1.23
Abdominal aortic aneurysms: recent experience with 210 patients. Can Med Assoc J (1978) 1.21
The nasFEDCBA operon for nitrate and nitrite assimilation in Klebsiella pneumoniae M5al. J Bacteriol (1994) 1.20
Cardiomyocyte transplantation improves heart function. Ann Thorac Surg (1996) 1.20
Reference-based pricing of prescription drugs. Can J Cardiol (1997) 1.19
Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol (1999) 1.19
Metabolic and structural changes in skeletal muscle during hypocaloric dieting. Am J Clin Nutr (1984) 1.18
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther (2006) 1.18
Temporary epicardial pacing after open heart surgery: complications and prevention. J Card Surg (1989) 1.17
Cardiovascular effects of protamine sulfate. Ann Thorac Surg (1969) 1.17
Placing patients in the queue for coronary surgery: do age and work status alter Canadian specialists' decisions? J Gen Intern Med (1992) 1.17
Results of aortic valve-sparing operations. J Thorac Cardiovasc Surg (2001) 1.15
Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. Can J Cardiol (1993) 1.14
5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg (1987) 1.14
Left ventricular mass regression early after aortic valve replacement. Ann Thorac Surg (1996) 1.13